Netbasequid
FEBRUARY 22, 2021
Want to know how many biotech companies have received private funding over the last ten years? Search for biotech companies receiving private funding over the last ten years. From here, the biotech world is your oyster. The Quid product encourages a deep dive into insights uncovered through the power of visualized data.
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 Sign up for your free trial today.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alpha Sense BI
JANUARY 25, 2023
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Alpha Sense BI
AUGUST 30, 2023
Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market. Artificial intelligence is the only way to do it.
Alpha Sense BI
MAY 28, 2024
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.
BIS Research
MARCH 19, 2019
According to the recent market intelligence report published by BIS Research, titled Global Precision Medicine Market – Analysis and Forecast (2018 – 2028) , the precision medicine market was estimated at $78.85 billion in 2018 and is expected to reach $216.75 billion by 2028.
Sedulo
MARCH 15, 2023
Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)
Expert insights. Personalized for you.
98 
Let's personalize your content